Nanjing Libravo Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is CLEVIDIPINE BUTYRATE, NON-STERILE ACTIVE PHARMACEUTICAL INGREDIENT, with a corresponding US DMF Number 37767.
Remarkably, this DMF maintains an Active status since its submission on December 22, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 28, 2025, and payment made on February 18, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II